{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:25:07Z","timestamp":1777350307029,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Li Shu Pui Medical Foundation Research Grant, Li Ka Shing Faculty of Medicine, The University of Hong Kong"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12072-022-10305-y","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:03:54Z","timestamp":1648512234000},"page":"371-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Rex Wan-Hin","family":"Hui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert Chi-Yan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cura","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarence Nicholas","family":"Kotewall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lung-Yi","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wong-Hoi","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kin-Pan","family":"Au","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Fung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-313X","authenticated-orcid":false,"given":"Wai-Kay","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"10305_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"10305_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6","journal-title":"Nat Rev Dis Primers"},{"key":"10305_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Br\u00fa C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329\u2013338","journal-title":"Semin Liver Dis"},{"key":"10305_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723\u2013750","journal-title":"Hepatology"},{"key":"10305_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, et al. Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289:816\u2013830","journal-title":"Radiology"},{"key":"10305_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng A-L, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hep Int. 2017;11:317\u2013370","journal-title":"Hep Int"},{"key":"10305_CR7","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s00330-017-5278-x","volume":"28","author":"DH Lee","year":"2018","unstructured":"Lee DH, Lee JM, Chang W, et al. Prognostic role of liver stiffness measurements using magnetic resonance elastography in patients with compensated chronic liver disease. Eur Radiol. 2018;28:3513\u20133521","journal-title":"Eur Radiol"},{"key":"10305_CR8","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1007\/s00261-020-02684-3","volume":"45","author":"HB Thomaides-Brears","year":"2020","unstructured":"Thomaides-Brears HB, Lepe R, Banerjee R, et al. Multiparametric MR mapping in clinical decision-making for diffuse liver disease. Abdom Radiol (NY). 2020;45:3507\u20133522","journal-title":"Abdom Radiol (NY)"},{"key":"10305_CR9","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1007\/s00330-020-06792-y","volume":"30","author":"HJ Cho","year":"2020","unstructured":"Cho HJ, Kim B, Kim HJ, et al. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment. Eur Radiol. 2020;30:4182\u20134192","journal-title":"Eur Radiol"},{"key":"10305_CR10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2214\/AJR.12.8632","volume":"199","author":"S Siripongsakun","year":"2012","unstructured":"Siripongsakun S, Lee JK, Raman SS, et al. MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis. AJR Am J Roentgenol. 2012;199:1018\u20131025","journal-title":"AJR Am J Roentgenol"},{"key":"10305_CR11","unstructured":"International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. http:\/\/www.idf.org\/webdata\/docs\/MetS_def_update2006.pdf. Accessed 22 July 2016."},{"key":"10305_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91\u201396","journal-title":"Gastroenterology"},{"key":"10305_CR13","first-page":"1","volume":"1","author":"CG Child","year":"1964","unstructured":"Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1\u201385","journal-title":"Major Probl Clin Surg"},{"key":"10305_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/SLA.0000000000003433","volume":"273","author":"A Chan","year":"2021","unstructured":"Chan A, Zhang WY, Chok K, et al. ALPPS versus portal vein embolization for hepatitis-related hepatocellular carcinoma: a changing paradigm in modulation of future liver remnant before major hepatectomy. Ann Surg. 2021;273:957\u2013965","journal-title":"Ann Surg"},{"key":"10305_CR15","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696\u2013699","journal-title":"J Hepatol"},{"key":"10305_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/gut.2008.164053","volume":"58","author":"T Ohki","year":"2009","unstructured":"Ohki T, Tateishi R, Shiina S, et al. Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut. 2009;58:839\u2013844","journal-title":"Gut"},{"key":"10305_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ags3.12183","volume":"2","author":"H Shinkawa","year":"2018","unstructured":"Shinkawa H, Tanaka S, Takemura S, et al. Obesity and recurrence-free survival in patients with hepatocellular carcinoma after achieving sustained virological response to interferon therapy for chronic hepatitis C. Ann Gastroenterol Surg. 2018;2:319\u2013326","journal-title":"Ann Gastroenterol Surg"},{"key":"10305_CR18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jhep.2020.05.040","volume":"73","author":"LY Mak","year":"2020","unstructured":"Mak LY, Hui RW, Fung J, et al. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. J Hepatol. 2020;73:800\u2013806","journal-title":"J Hepatol"},{"key":"10305_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/jvh.12766","volume":"25","author":"RWH Hui","year":"2018","unstructured":"Hui RWH, Seto WK, Cheung KS, et al. Inverse relationship between hepatic steatosis and hepatitis B viremia: results of a large case-control study. J Viral Hepatitis. 2018;25:97\u2013104","journal-title":"J Viral Hepatitis"},{"key":"10305_CR20","doi-asserted-by":"publisher","first-page":"14561","DOI":"10.1038\/s41598-017-14706-0","volume":"7","author":"S Lallukka","year":"2017","unstructured":"Lallukka S, S\u00e4devirta S, Kallio MT, et al. Predictors of liver fat and stiffness in non-alcoholic fatty liver disease (NAFLD)\u2014an 11-year prospective study. Sci Rep. 2017;7:14561","journal-title":"Sci Rep"},{"key":"10305_CR21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1365-2036.2007.03302.x","volume":"25","author":"P Mathurin","year":"2007","unstructured":"Mathurin P, Beuzin F, Louvet A, et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther. 2007;25:1047\u20131054","journal-title":"Aliment Pharmacol Ther"},{"key":"10305_CR22","first-page":"389","volume":"74","author":"B Vos","year":"2011","unstructured":"Vos B, Moreno C, Nagy N, et al. Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. Acta Gastro-Enterol Belg. 2011;74:389\u2013394","journal-title":"Acta Gastro-Enterol Belg"},{"key":"10305_CR23","doi-asserted-by":"publisher","first-page":"100067","DOI":"10.1016\/j.jhepr.2020.100067","volume":"2","author":"K Patel","year":"2020","unstructured":"Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020;2:100067","journal-title":"JHEP Rep"},{"key":"10305_CR24","doi-asserted-by":"crossref","unstructured":"Bae JS, Lee DH, Yi NJ, et al. Magnetic resonance elastography versus transient elastography in the prediction of complications after resection for hepatocellular carcinoma. Ann Surg. 2020","DOI":"10.1097\/SLA.0000000000004576"},{"key":"10305_CR25","doi-asserted-by":"crossref","unstructured":"Singh S, Fujii LL, Murad MH et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1573\u20131584.e1571\u20131572 (quiz e1588\u20131579)","DOI":"10.1016\/j.cgh.2013.07.034"},{"key":"10305_CR26","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1002\/jmri.26638","volume":"49","author":"S Geethanath","year":"2019","unstructured":"Geethanath S, Vaughan JT Jr. Accessible magnetic resonance imaging: a review. J Magnet Resonance Imaging (JMRI). 2019;49:e65\u2013e77","journal-title":"J Magnet Resonance Imaging (JMRI)"},{"key":"10305_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ultrasmedbio.2013.08.011","volume":"40","author":"W Ling","year":"2014","unstructured":"Ling W, Lu Q, Lu C, et al. Effects of vascularity and differentiation of hepatocellular carcinoma on tumor and liver stiffness: in vivo and in vitro studies. Ultrasound Med Biol. 2014;40:739\u2013746","journal-title":"Ultrasound Med Biol"},{"key":"10305_CR28","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","volume":"69","author":"AWH Chan","year":"2018","unstructured":"Chan AWH, Zhong J, Berhane S, et al. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol. 2018;69:1284\u20131293","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10305-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T10:05:16Z","timestamp":1650189916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10305-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10305"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10305-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MF Yuen is an advisory board member and\/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. WK Seto received speaker\u2019s fees from AstraZeneca and Mylan, is an advisory board member of CSL Behring, is an advisory board member and received speaker\u2019s fees from AbbVie, and is an advisory board member, received speaker\u2019s fees and researching funding from Gilead Sciences. The other authors have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal research (ethics)"}},{"value":"All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate (ethics)"}},{"value":"Informed consent was obtained from all individual participants included in this study. No identifiable personal data from recruited patients were included in this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish (ethics)"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Plant reproducibility"}},{"value":"This study was registered and approved by the Institutional Review Board, University of Hong Kong\/ Hospital Authority West Cluster; and the Research Ethics Committee, Hong Kong Sanatorium and Hospital.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration and ethical approval"}}]}}